NDC 13668-0014 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13668-0014
- Manufacturer
- Rebel Distributors Corp
- Effective date
- 2010-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - Rebel Distributors Corp | Rebel Distributors Corp | 2010-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | Major Pharmaceuticals | 423d2185-0931-4414-8864-7594000809ee | 2024-07-31 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam Extended-Release | LEVETIRACETAM | ScieGen Pharmaceuticals, Inc | 3e32f341-9926-47a3-a942-d8b9bfa7a55b | 2024-07-12 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | American Health Packaging | 031a32e1-675a-4efe-a66b-40beb4fe5101 | 2024-06-21 | Warnings, Adverse reactions | 387003 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Amneal Pharmaceuticals LLC | 5c4877cc-52bc-4f98-a995-0aa9439da742 | 2024-06-11 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam ER | LEVETIRACETAM | Westminster Pharmaceuticals, LLC | c508a392-0603-477d-8a45-3ec550371111 | 2024-06-10 | Warnings, Adverse reactions | 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Hospira, Inc. | f1935bc8-30ce-4b51-8a4c-0f12ce9000a6 | 2024-06-05 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | bc8b413f-2f07-4e6a-bb8e-a1f2119ae1cf | 2024-05-30 | Warnings, Adverse reactions | 311290 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Actavis Pharma, Inc. | 5cb4a1db-f32d-44af-8985-0a94ca506468 | 2024-05-30 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | adbcb0f7-0421-47e2-854e-e1cfefb6386f | 2024-05-29 | Warnings, Adverse reactions | 311288 311289 44YRR34555 |
| levetiracetam | LEVETIRACETAM | Mylan Institutional LLC | e86dc508-4d22-493b-bdf1-408b6484d3f1 | 2024-05-28 | Warnings, Adverse reactions | 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Hospira, Inc. | ed1b74a8-2a9b-4315-b051-673c7941cb13 | 2024-05-14 | Warnings, Adverse reactions | 44YRR34555 |
| levetiracetam | LEVETIRACETAM | Baxter Healthcare Corporation | 3d88adda-9580-44bf-b75c-d615c973c1e1 | 2024-05-06 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam in Sodium Chloride | LEVETIRACETAM | Nexus Pharmaceuticals LLC | ee014183-a857-457b-9573-0cc168e560f3 | 2024-04-30 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Camber Pharmaceuticals, Inc. | 63b36274-89f0-42d8-9f09-f9e78e179af4 | 2024-04-29 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | B. Braun Medical Inc. | ad32ec2f-b4e0-4811-8ea1-7a4abdd5c0a6 | 2024-04-23 | Warnings, Adverse reactions | 44YRR34555 |
| levetiracetam | LEVETIRACETAM | Sagent Pharmaceuticals | d2de9565-0c0b-4957-bafa-1a286103709e | 2024-04-18 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam in Sodium Chloride | LEVETIRACETAM IN SODIUM CHLORIDE | Hikma Pharmaceuticals USA Inc. | c723fd27-214c-45f6-b170-a3b807ffab07 | 2024-04-12 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Aurobindo Pharma Limited | 2471ee03-d747-4113-86d0-1aa93c8f3eba | 2024-04-04 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Novadoz Pharmaceuticals LLC | 484e8d8f-be40-46f8-a509-d1bbdbbd2981 | 2024-04-04 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | ed8e88d0-993e-4683-bdcf-31578130d3df | 2024-04-03 | Warnings, Adverse reactions | 387003 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.